Amarin News - AMRN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Amarin AMRN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.44 2.61% 17.27 17.42 16.78 16.95 16.83 11:39:13
more quote information »

Recent News

Date Time Source Heading
5/20/20192:22IHNWPromotedBillboard-charting Songwriter & Recording Artist OG Maco Signs with Pro Music Rights
5/16/201916:15GLOBEVascepa® to Be Featured in Multiple Scientific Sessions at..
5/01/201905:00GLOBEAmarin Reports First Quarter 2019 Financial Results and..
4/29/201906:00GLOBENew Drug Submission Filed for Vascepa® with Health Canada
4/25/201907:02EDGARProxy Statement (definitive) (def 14a)
4/24/201906:00GLOBEAmarin To Report First Quarter 2019 Results and Host..
4/15/201917:08EDGARProxy Statement - Notice of Shareholders Meeting..
3/29/201917:45GLOBEVascepa® Granted Priority Review Status from Health Canada
3/28/201916:51GLOBEAmarin Submits Supplemental New Drug Application (sNDA) to..
3/28/201905:00GLOBENew Updates to the American Diabetes Association’s® 2019..
3/19/201906:00GLOBECardiovascular Risk at Multiple Triglyceride Thresholds..
3/18/201916:15GLOBEAdditional Real-World Data Show a Significant Risk Increase..
3/18/201909:00PRNUSVascepa® (icosapent ethyl) Showed 30% Reduction in Total..
3/16/201917:30GLOBEHigh Risk of Atherosclerotic Cardiovascular Events Projected..
3/06/201908:25GLOBEInvestor Expectations to Drive Momentum within Amarin,..
3/05/201906:00GLOBEAmarin to Present at Cowen’s 39th Annual Health Care..
3/04/201916:30GLOBEImportant New Data on Vascepa® (Icosapent Ethyl) from the..
3/01/201917:00BWAMARIN INVESTOR ALERT: Gibbs Law Group Has Filed Sole Class..
2/27/201914:25BWIMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces..
2/27/201906:39EDGARAnnual Report (10-k)
2/27/201905:00GLOBEAmarin Reports Record Fourth Quarter and Full Year 2018..
2/26/201922:24BWIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the..
2/22/201918:18BWAMARIN CORPORATION INVESTOR ALERT: Gibbs Law Group Files..
2/19/201906:00GLOBEAmarin To Report Fourth Quarter and Full Year 2018 Results..
2/14/201906:00GLOBEAmarin to Present at the 8th Annual SVB Leerink Global..
1/23/201906:00GLOBENew REDUCE-IT™ Trial Data Showing the Total Reduction in..
1/04/201916:15GLOBEAmarin Provides Preliminary 2018 Results and 2019 Outlook
1/02/201906:00GLOBEAmarin to Present at 37th Annual J.P. Morgan Healthcare..
11/29/201815:07EDGARSecurities Registration (ads, Immediate) (f-6ef)
11/28/201818:25GLOBEAmarin to Participate in a Fireside Chat at Citi’s 2018..
11/26/201820:59GLOBEAmarin Prices Public Offering of American Depositary Shares
11/26/201817:32EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/26/201816:23GLOBEAmarin Announces Proposed Public Offering of American..
11/20/201806:00GLOBEAmarin to Present at the Evercore ISI HealthCONx Conference
11/11/201810:32PRNUSVascepa® (icosapent ethyl) 26% Reduction in Key Secondary..
11/08/201806:00GLOBEAmarin to Present at the Jefferies 2018 London Healthcare..
11/01/201805:00GLOBEAmarin Reports Third Quarter 2018 Financial Results and..
10/26/201805:00GLOBEAmarin Schedules Webcast Discussion of Primary REDUCE-IT™..
10/25/201806:00GLOBEAmarin To Report Third Quarter 2018 Results and Host..
10/19/201816:15GLOBEAmarin Announces Mandatory Exchange of Exchangeable Senior..
10/10/201817:11EDGARAmended Statement of Ownership (sc 13g/a)
9/27/201817:19GLOBEAmarin to Present at the Cantor Global Healthcare Conference
9/24/201804:30GLOBEREDUCE-IT™ Cardiovascular Outcomes Study of Vascepa®..
9/12/201809:21GLOBEREDUCE-IT™ Trial Primary Results Accepted for Presentation..
8/26/201811:00GLOBEAmarin’s REDUCE-IT™ Clinical Study Now Positioned to be Next..
8/25/201805:00GLOBEReal-World Data Supports Association Between Elevated..
8/01/201806:38EDGARQuarterly Report (10-q)
8/01/201805:00GLOBEAmarin Reports Second Quarter 2018 Financial Results and..
7/26/201808:48GLOBEAmarin Announces Approval for Vascepa® in United Arab..
7/24/201805:00GLOBEAmarin to Report Second Quarter 2018 Results and Host..
7/03/201816:15EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.